Implandata Ophthalmic Products, a digital eye care company based in Germany and USA, was awarded 1st place at the Healthcare Innovation World Cup at MEDICA.
The competition saw 300 healthtech companies from 60 countries, with Implandata and its disruptive Eyemate system were recognised by the expert jury as the top digital health solution based on the level of innovation, go-to-market-approach, commercial potential and sustainability.
Max Ostermeier, CEO and founder of the company, said: “The Implandata team is very excited and proud to win this prestigious award. It confirms the high degree of innovation of our Eyemate system, and the huge market opportunity it addresses.”
Dominick Arena, chairman of the company, added: “Implandata is currently preparing the European market launch of the Eyemate system and has started the US market FDA approval process. The company will build a strong business foundation on the sales of Eyemate biosensors and recurring revenues for remote patient monitoring and therapy guidance services.”
